Point of Care Ultrasound Market Report 2026

The point of care ultrasound market size has grown strongly in recent years. It will grow from $4.54 billion in 2025 to $4.88 billion in 2026 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to increasing demand for real-time diagnostic imaging, expansion of emergency and critical care services, adoption of portable medical devices, growth of point-of-care clinical practices, improved ultrasound hardware miniaturization.

The point of care ultrasound market size is expected to see strong growth in the next few years. It will grow to $6.55 billion in 2030 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to growing adoption of ai-enabled ultrasound systems, rising demand for handheld imaging devices, expansion of pocus training programs, increasing use in outpatient and ambulatory settings, growing integration with electronic health records. Major trends in the forecast period include increasing adoption of handheld ultrasound devices, rising use of bedside imaging in emergency care, growing integration of AI-assisted image interpretation, expansion of portable diagnostic ultrasound applications, enhanced focus on rapid clinical decision support.

The increasing prevalence of chronic diseases is expected to drive the growth of the point of care ultrasound market going forward. Chronic or non communicable diseases are long term medical conditions that persist over time and typically progress gradually. Point of care ultrasound supports early disease detection, personalized treatment approaches, and remote monitoring, positioning it as an important tool in the management of chronic conditions and in improving patient outcomes. For instance, in January 2023, according to the National Institutes of Health, a US-based government agency, by 2035, around 35.66% of adults aged 50 years and older are projected to have at least one chronic condition, a figure that is expected to increase to 47.81% by 2050. Therefore, the growing burden of chronic diseases is driving the expansion of the point of care ultrasound market.

Major companies operating in the point of care ultrasound market are focusing on the development of technologically advanced solutions, such as ultrasound on chip technology, to strengthen imaging performance and gain a competitive advantage. Ultrasound on chip technology integrates ultrasound components onto a single chip, enabling the creation of compact and portable ultrasound systems for a wide range of medical imaging applications. This advancement improves accessibility to ultrasound diagnostics and supports further innovation in point of care and wearable healthcare technologies. For instance, in February 2024, Butterfly Network Inc., a US-based medical imaging device manufacturer, introduced the Butterfly iQ3, the latest version of its handheld point of care ultrasound system. The device uses P4.3 ultrasound on chip technology and offers the world’s fastest digital data transfer rate. It is designed to deliver improved high resolution imaging, advanced 3D capabilities, and enhanced portability, with double the processing power compared to its predecessor, the Butterfly iQ+.

In August 2024, Roche Holding AG, a Switzerland-based healthcare company, acquired LumiraDx’s point of care technology for approximately $295 million. Through this acquisition, Roche seeks to strengthen its diagnostics portfolio by incorporating LumiraDx’s easy to use platform, which integrates a broad range of immunoassay and clinical chemistry tests into a single system. This transaction reflects the increasing demand within the healthcare sector for simple and efficient point of care diagnostic solutions. LumiraDx is a UK-based company that develops point of care diagnostic tools and devices, including ultrasound technologies for various medical applications.

Major companies operating in the point of care ultrasound market are Samsung Electronics Co. Ltd., Hitachi Ltd., Siemens Healthineers GmbH, Fujifilm Holdings Corporation, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Toshiba Medical Systems Corporation, Fukuda Denshi Co. Ltd., FUJIFILM Sonosite Inc., Analogic Corporation, Esaote SPA, Zimmer MedizinSysteme GmbH, Chison Medical Imaging Co. Ltd., Butterfly Network Inc., Terason Division Teratech Corporation, ALPINION Medical Systems Co. Ltd., Shenzhen AnaSonic Bio-Medical Technology Co. Ltd., Healcerion Co. Ltd., Edan Instruments Inc., Shenzhen Landwind Industry Co. Ltd., United Imaging Healthcare, Mindray Medical International Limited, Samsung Medison Co. Ltd.

North America was the largest region in the point of care ultrasound market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point of care ultrasound market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the point of care ultrasound market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the point-of-care ultrasound market by increasing costs of imported imaging sensors, transducers, semiconductor components, and display modules used in handheld and trolley-based systems. Hospitals and clinics in North America and Europe are most affected due to dependence on imported ultrasound hardware, while Asia-Pacific faces cost pressures on device exports. These tariffs are raising equipment acquisition costs and slowing replacement cycles. At the same time, they are encouraging regional assembly, domestic component sourcing, and innovation in cost-optimized portable ultrasound platforms.

The point of care ultrasound market research report is one of a series of new reports that provides point of care ultrasound market statistics, including point of care ultrasound industry global market size, regional shares, competitors with a point of care ultrasound market share, detailed point of care ultrasound market segments, market trends and opportunities, and any further data you may need to thrive in the point of care ultrasound industry. This point of care ultrasound market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Point of care ultrasound refers to the use of portable ultrasound devices at the patient’s bedside or within clinical settings for immediate diagnostic and therapeutic purposes. This approach provides benefits such as real time assessment, instant feedback, and faster clinical decision making.

The primary types of point of care ultrasound include diagnostic devices and therapeutic devices. Diagnostic devices are medical tools used by healthcare professionals to detect and confirm diseases, conditions, or abnormalities in patients. Based on portability, these devices include trolley based systems and handheld units. Point of care ultrasound is applied across areas such as emergency medicine, cardiology, obstetrics and gynecology, urology, vascular surgery, and musculoskeletal care, and is used by end users including hospitals, clinics, maternity centers, ambulatory surgical centers, and other healthcare facilities.

The point-of-care ultrasound market consists of sales of handheld ultrasound scanners, ultrasound transducers, ultrasound gel, accessories and consumables, and vascular access ultrasound guidance kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.